[Clinicopathological study of pulp protection with various indirect pulp capping methods prior to silicate cement filling].
D000293:Adolescent; D000328:Adult; D003782:Dental Pulp / Q000187:drug effects* / Q000473:pathology; D003785:Dental Pulp Capping; D003794:Dental Restoration, Temporary; D003804:Dentin / Q000473:pathology; D005260:Female; D005557:Formaldehyde; D006470:Hemorrhage / Q000473:pathology; D006801:Humans; D006940:Hyperemia / Q000473:pathology; D008277:Magnesium Oxide / Q000494:pharmacology; D008297:Male; D008875:Middle Aged; D009804:Odontoblasts / Q000473:pathology; D010710:Phosphates / Q000494:pharmacology; D012677:Sensation; D012823:Silicate Cement; D013492:Suppuration / Q000473:pathology; D014098:Toothache; D015035:Zinc Oxide-Eugenol Cement / Q000494:pharmacology*
D010710:Phosphates; D015035:Zinc Oxide-Eugenol Cement; D012823:Silicate Cement; D005557:Formaldehyde; D008277:Magnesium Oxide